Rosanna McCalips has 10 years of experience defending pharmaceutical companies against antitrust lawsuits alleging a variety of exclusionary conduct. These proceedings have included sham Citizen Petition filings with the United States Food and Drug Administration (FDA), sham Hatch-Waxman Act patent infringement litigation, fraud on the United States Patent and Trademark Office (USPTO), abuse of FDA Risk Evaluation and Mitigation Systems (REMS) programs, and product hopping. She was a member of the defense team in one of the few pharmaceutical antitrust cases to go to trial, helping to obtain a full defense jury verdict for Sanofi-Aventis US LLC against a claim of monopolization based on the filing of an allegedly sham Citizen Petition with the FDA.
In addition to monopolization cases, Rosanna has experience defending companies against allegations of price-fixing conspiracies. Her other litigation experience includes cases involving claims against federal agencies under the Freedom of Information Act (FOIA) and the Administrative Procedure Act (APA), claims arising from credit card security breaches, claims of professional negligence related to Pap smear testing, and False Claims Act violations.
Representative clients include Laboratory Corporation of America, Sanofi-Aventis US LLC, Kyorin Pharmaceutical Co., and ViroPharma Incorporated.
Rosanna is active in pro bono activities. She has represented tenants in obtaining compensation from their landlords for violations of the housing code as part of the Firm's initiative to assist in the preservation of affordable housing in the District of Columbia. She also provides pro bono representation in guardianship and custody cases in the Domestic Relations Branch of the D.C. Superior Court.
Executive Order on Promoting Competition in the American Economy: A Focus on Patent and Drug Law to Reduce Health Care Spending
- September 18, 2017
Aspen Skiing: Do you have to have danced before?, ABA Webinar
- June 1, 2017
Antitrust Issues Arising from Pharmaceutical Drug Product Litigation
- January 19, 2017
REMS Abuse: Balancing Generic Competition, Innovation, and Safety Concerns in the Pharmaceutical Industry, California Lawyers Association Webinar
- May 16, 2013
New Antitrust Challenges for U.S. Companies Around the Globe
- University of Pennsylvania (J.D. 2002; Senior Editor, Journal of Labor and Employment Law); Pennsylvania State University (Schreyer Honors College: B.A. in Spanish and Political Science, with honors in Spanish, 1999; Phi Beta Kappa)
- Pennsylvania, District of Columbia, District of Columbia Court of Appeals, and the U.S. District Court for the District of Columbia
*Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice